St. Louis Cancer Care, LLP — Bridgeton, Missouri

St. Louis Cancer Care, LLP is a clinical research site located in Bridgeton, Missouri, United States 63044.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Louis Cancer Care, LLP has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Non-small Cell Lung Cancer.

Sponsors: EMD Serono Research & Development Institute, Inc., Boehringer Ingelheim, Dendreon.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Louis Cancer Care, LLP?

St. Louis Cancer Care, LLP has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Louis Cancer Care, LLP conducted?

St. Louis Cancer Care, LLP has 7 clinical trials on record, with 3 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Non-small Cell Lung Cancer.

Is St. Louis Cancer Care, LLP accredited by Crixeo Health?

Yes — St. Louis Cancer Care, LLP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Louis Cancer Care, LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.